Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors

被引:24
|
作者
Dong, Jinyun [1 ,2 ,4 ]
Huang, Guang [1 ]
Cui, Qing [1 ]
Meng, Qingqing [1 ]
Li, Shaoshun [1 ]
Cui, Jiahua [1 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Pharm, 800 Dongchuan Rd, Shanghai, Peoples R China
[2] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, 800 Dongchuan Rd, Shanghai, Peoples R China
[4] Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
CYP1; enzymes; CYP1B1; inhibitors; alpha-Naphthoflavone derivatives; SARs; DNA ADDUCT FORMATION; DESIGN; RESISTANCE; EXPRESSION; ANALOGS;
D O I
10.1016/j.ejmech.2020.112895
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cytochrome P450 1B1 (CYP1B1) has been well validated as an attractive target for cancer prevention and drug resistance reversal. In continuation of our interest in this area, herein, a set of forty-six 6,7,10-trimethoxy-alpha-naphthoflavone derivatives varying in B ring was synthesized and screened against CYP1 enzymes, leading to the identification of fluorine-containing compound 15i as the most potent and selective CYP1B1 inhibitor (IC50 value of 0.07 nM), being 84-fold more potent than that of the template molecule ANF. Alternatively, the amino-substituted derivative 13h not only possessed a potent inhibitory effect on CYP1B1 (IC50 value of 0.98 nM), but also had a substantially increased water solubility as compared with the lead ANF (311 mu g/mL for 13h and <5 mu g/mL for ANF). The current study expanded the structural diversity of CYP1B1 inhibitors, and compound 13h could be considered as a promising starting point with great potential for further studies. (c) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Discovery of 1H-Imidazo[4,5-b]pyridine Derivatives as Potent and Selective BET Inhibitors for the Management of Neuropathic Pain
    Chen, Xuetao
    Cao, Danyan
    Liu, Chihong
    Meng, Fanying
    Zhang, Zijian
    Xu, Rujun
    Tong, Yuanyuan
    Xin, Yabing
    Zhang, Weikun
    Kang, Wenjing
    Bao, Qichao
    Shen, Jingkang
    Xiong, Bing
    You, Qidong
    Jiang, Zhengyu
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (13) : 8725 - 8744
  • [22] Design of Novel 2-Phenylquinazolin-4-amines as Selective CYP1B1 Inhibitors for Overcoming Paclitaxel Resistance in A549 Cells
    Yang, Meixian
    Yang, Fengyuan
    Huang, Xinyue
    Cai, Jiajing
    Zhang, Yuxin
    Jia, Jianhua
    Qiu, Dachuan
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (07) : 5883 - 5901
  • [23] Discovery of C-5 Pyrazole-Substituted Pyrrolopyridine Derivatives as Potent and Selective Inhibitors for Janus Kinase 1
    Lang, Jia-Jia
    Lv, You
    Kobe, Bostjan
    Chen, Hongfei
    Tan, Yan
    Chen, Limei
    Wang, Xuechuan
    Mi, Pengbing
    Zheng, Xing
    Lin, Ying-Wu
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (10) : 6725 - 6742
  • [24] Structural optimization of pyrazolo[1,5-a]pyrimidine derivatives as potent and highly selective DPP-4 inhibitors
    Shen, Jian
    Deng, Xinxian
    Sun, Ran
    Tavallaie, Mojdeh S.
    Wang, Juntao
    Cai, Qingqing
    Lam, Celine
    Lei, Shuwen
    Fu, Lei
    Jiang, Faqin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
  • [25] Discovery of N-Substituted Oseltamivir Derivatives as Potent and Selective Inhibitors of H5N1 Influenza Neuraminidase
    Xie, Yuanchao
    Xu, Dongqing
    Huang, Bing
    Ma, Xiuli
    Qi, Wenbao
    Shi, Fangyuan
    Liu, Xinyong
    Zhang, Yingjie
    Xu, Wenfang
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (20) : 8445 - 8458
  • [26] Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors
    Liu, Zhenzhen
    Zhao, Taoqian
    Li, Zhonghua
    Sun, Kai
    Fu, Yundong
    Cheng, Ting
    Guo, Jimin
    Yu, Bin
    Shi, Xiaojing
    Liu, Hongmin
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (08) : 1476 - 1491
  • [27] Discovery of novel 2,3-dihydro-1H-inden-1-amine derivatives as selective monoamine oxidase B inhibitors
    Li, Shiyu
    Lv, Xiao
    Cheng, Kai
    Tian, Yongbing
    Huang, Xufeng
    Kong, Haiyan
    Duan, Yajun
    Han, Jihong
    Liao, Chenzhong
    Xie, Zhouling
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (09) : 1090 - 1093
  • [28] From hit to lead: Structure-based discovery of naphthalene-1 sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4
    Gao, Ding-Ding
    Dou, Hui-Xia
    Su, Hai-Xia
    Zhang, Ming-Ming
    Wang, Ting
    Liu, Qiu-Feng
    Cai, Hai-Yan
    Ding, Hai-Peng
    Yang, Zhuo
    Zhu, Wei-Liang
    Xu, Ye-Chun
    Wang, He-Yao
    Li, Ying-Xia
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 154 : 44 - 59
  • [29] Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity
    Zhang, Li
    Zhao, Jingyun
    Zhang, Beichen
    Lu, Tao
    Chen, Yadong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 : 809 - 816
  • [30] Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity
    Hao, Yongjin
    Yang, Chengkui
    Shu, Chang
    Li, Zhanhui
    Xia, Kaijiang
    Wu, Shuwei
    Ma, Haikuo
    Tian, Sheng
    Ji, Yuting
    Li, Jingjing
    He, Sudan
    Zhang, Xiaohu
    BIOORGANIC CHEMISTRY, 2022, 129